Send feedback

AGBL5 p.Arg489His

c.1466G>A · rs202108566 · VCV844256

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely pathogenic
0.7815 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.099%, mid)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
inherited retinal dystrophy

Computational evidence

Protein change
AlphaMissense0.7815likely pathogenic
REVEL0.312indeterminate
SaProtLLR -11.13damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.5, phastCons 1
Regional constrainto/e 0.80unconstrained · MANE · 4,357 bp · p 1.1e-07 · regional, not allelic
Overall
CADD32.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.099% Middle Eastern · 6/6,060 alleles
Filtering AF 0.043% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0295%
Overall 0.019% 306/1,613,732 alleles · ultra-rare
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 0.11% 912
Middle Easterngrpmax 0.099% 1,010
Remaining individualsnot grpmax-eligible 0.0384% 2,603
South Asian 0.0286% 3,501
Admixed American 0.02% 5,001
European (non-Finnish) 0.0194% 5,152
African / African-American 0.008% 12,505
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,592
Finnishnot grpmax-eligible 0.00156% 64,000

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AGBL5
Protein
p.Arg489His
Coding
c.1466G>A
MANE Select
NM_021831
dbSNP
rs202108566
Type
single nucleotide variant
Location
chr2:27056723 (GRCh38)
Gene constraint
LOEUF 0.709 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 71.36 · 10 PDB
Residue 489
the peptidase m14 domain; a UniProt-annotated variant site (found in patients with a usher-like phenotype encompassing rp and hearing loss; likely pathogenic); a UniProt-annotated variant site (in rp75); a β-strand
Full AGBL5 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/agbl5-p-arg489his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown